+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID07859722

Randomized Study Comparing CT Alone Versus Combined CT and MRI Planning for High-Dose-Rate Prostate Brachytherapy in Prostate Cancer

Led by Emory University · Updated on 2026-11-02

100

Participants Needed

3

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety of using computed tomography CT scans with or without magnetic resonance imaging MRI scans for planning high-dose-rate HDR prostate brachytherapy in men with prostate cancer. Brachytherapy involves placing radioactive implants near or inside the tumor to deliver radiation directly. This study aims to compare patient-reported urinary toxicity and other side effects between planning with CT alone and planning with CT plus MRI. Participants are randomly assigned to one of two groups one group receives treatment planning using only a CT scan, while the other group receives planning with both a CT scan and an MRI scan. After treatment planning, patients undergo HDR brachytherapy and may also receive external beam radiation therapy. The addition of MRI to CT planning may help reduce urinary leakage and pain after treatment. During the study, patients complete questionnaires measuring urinary, bowel, and sexual function at 1, 3, 6, and 12 months after treatment. Researchers also monitor side effects reported by physicians during this time. The main outcome measured is the urinary incontinence score one month after treatment. Follow-up visits occur over a year to assess acute and chronic treatment effects and overall treatment efficacy.

CONDITIONS

Brief Title

CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer

Research Team

K

Kamran Salari, MD

S

Sagar Patel, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here